Susan L Cohn Selected Research

Therapeutics

3/2024	Impact of Risk-Based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the childhood cancer survivor study.
12/2023	Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey study.
10/2023	Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
1/2023	Multimodality treatment for recurrent neuroblastoma in the central nervous system.
12/2022	Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.
9/2022	The Experience of Children With Neuroblastoma and Their Parents During Single-Room Isolation for 131I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive Study.
1/2022	Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
12/2021	Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group.
11/2021	Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
1/2021	A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan L Cohn Research Topics

Disease

100	Neuroblastoma 04/2024 - 01/2002
67	Neoplasms (Cancer) 04/2024 - 07/2003
4	Hypersensitivity (Allergy) 12/2022 - 09/2010
4	Hypoxia (Hypoxemia) 12/2022 - 11/2010
4	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2008
3	Hypotension (Low Blood Pressure) 12/2022 - 11/2010
3	Pain (Aches) 09/2022 - 09/2010
3	Chromosome Aberrations (Chromosome Abnormalities) 10/2021 - 10/2014
3	Ganglioneuroma 03/2013 - 12/2004
2	Neurologic Manifestations (Neurological Manifestations) 01/2020 - 12/2015
2	Residual Neoplasm 01/2019 - 09/2013
2	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2018 - 03/2008
2	Ganglioneuroblastoma 03/2013 - 10/2009
1	Inflammation (Inflammations) 06/2023
1	Fever (Fevers) 12/2022
1	Disease Progression 01/2021
1	Hypertrophy 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2020
1	Microsatellite Instability 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Hepatomegaly 10/2019
1	Thymus Hyperplasia 01/2017

Drug/Important Bio-Agent (IBA)

10	3-Iodobenzylguanidine (Iobenguane)IBA 12/2021 - 10/2004
9	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 09/2005
8	Biomarkers (Surrogate Marker)IBA 10/2021 - 11/2005
6	dinutuximabIBA 12/2022 - 09/2010
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2010
5	5-hydroxymethylcytosineIBA 01/2024 - 11/2016
5	Interleukin-2 (IL2)IBA 12/2022 - 09/2010
5	Monoclonal AntibodiesIBA 05/2017 - 09/2010
5	ABT751IBA 06/2014 - 08/2006
4	ChromatinIBA 01/2024 - 05/2012
4	RNA (Ribonucleic Acid)IBA 06/2023 - 05/2014
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2022 - 09/2010
4	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 04/2005
4	N-Myc Proto-Oncogene ProteinIBA 01/2021 - 03/2013
4	Angiogenesis InhibitorsIBA 06/2007 - 10/2003
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2024 - 06/2023
3	Cell-Free Nucleic AcidsIBA 01/2024 - 01/2020
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 11/2008
3	Ferritins (Ferritin)IBA 01/2020 - 10/2014
3	Phosphotransferases (Kinase)IBA 01/2019 - 10/2012
3	Isotretinoin (Accutane)FDA LinkGeneric 01/2018 - 09/2010
3	Indicators and Reagents (Reagents)IBA 04/2013 - 04/2005
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2011 - 12/2005
3	multidrug resistance-associated protein 1IBA 04/2006 - 01/2004
2	Vorinostat FDA Link 11/2021 - 06/2015
2	CytokinesIBA 01/2021 - 06/2013
2	Biological FactorsIBA 01/2021 - 01/2003
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 12/2018 - 01/2011
2	Cysteine (L-Cysteine)FDA Link 11/2016 - 06/2010
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2012 - 04/2007
2	Topotecan (Hycamtin)FDA LinkGeneric 11/2011 - 08/2010
2	Peptides (Polypeptides)IBA 06/2010 - 02/2007
2	FollistatinIBA 06/2010 - 10/2004
2	Tubulin ModulatorsIBA 02/2008 - 08/2006
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 02/2007 - 07/2003
2	CollagenIBA 01/2006 - 07/2004
2	Thrombospondin 1IBA 12/2004 - 10/2003
2	Messenger RNA (mRNA)IBA 10/2003 - 01/2002
1	6-methyladenineIBA 04/2024
1	Antineoplastic Agents (Antineoplastics)IBA 04/2024
1	Vincristine (Oncovin)FDA LinkGeneric 11/2021
1	pembrolizumabIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	OTS167IBA 01/2019
1	TabletsIBA 12/2018
1	MLN 8237IBA 12/2018
1	LigandsIBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Iodine-123IBA 08/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2017
1	Anaplastic Lymphoma KinaseIBA 12/2016
1	Insulin ReceptorIBA 12/2016
1	Codon (Codons)IBA 12/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2016
1	AlbuminsIBA 11/2016
1	LipidsIBA 11/2016
1	ParaffinIBA 06/2016
1	Formaldehyde (Formol)FDA Link 06/2016
1	Buthionine SulfoximineIBA 01/2016
1	Melphalan (Alkeran)FDA LinkGeneric 01/2016

Therapy/Procedure

44	Therapeutics 03/2024 - 05/2002
16	Drug Therapy (Chemotherapy) 12/2021 - 05/2002
10	Immunotherapy 12/2022 - 09/2010
7	Stem Cell Transplantation 01/2022 - 09/2010
4	Induction Chemotherapy 12/2021 - 04/2013
4	Radiotherapy 01/2019 - 09/2013
4	Aftercare (After-Treatment) 02/2013 - 07/2004
2	Duration of Therapy 12/2019 - 09/2010
2	Chemoradiotherapy 09/2013 - 06/2013
1	Palliative Care (Palliative Therapy) 12/2023
1	Radioimmunotherapy 01/2023
1	Urinary Catheters 09/2022
1	Terminal Care (Care, Terminal) 10/2020
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Investigational Therapies (Experimental Therapy) 01/2017
1	Continuity of Patient Care 11/2016